QR Code

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer

T-cell recruiting chemokines are required for a successful immune intervention in ovarian cancer, and also for the efficacy of modern anticancer agents such as PARP inhibitors. The chemokine CX3CL1 recruits tumour-suppressive T-cells into solid tumours, but also mediates cell–cell adhesions, e.g. of...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Stefanie Seitz, Tobias F. Dreyer, Christoph Stange, Katja Steiger, Dirk Wohlleber, Martina Anton, Thuý An Pham, Dominique Sauter-Peschke, Ute Reuning, Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2025-02-01
Rangatū:Neoplasia: An International Journal for Oncology Research
Ngā marau:
Chemokines
CX3CL1
Tumour-infiltrating lymphocytes
PARP inhibition
Mouse model
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S1476558625000090
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite